Production / Operations
Cannabix Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in Australia
Cannabix Expands Australian Footprint as MBT Certification Progresses Amidst Volatility

Executive Summary
- Cannabix Technologies Inc. announced the deployment of its BreathLogix alcohol screening technology into mining, municipal, and aviation sectors in Australia on May 29, 2026.
- Deployment is executed under an exclusive distribution partnership with Breathalyser Sales & Service Pty Ltd.
- The automated system enables workplace safety compliance through pre-shift testing, identity verification, and integration into access control workflows without dedicated administration personnel.
- Key features include contactless and straw modes, user photograph capture for identity verification, precise Blood Alcohol Content (BAC/BrAC) readings, and real-time SMS/email alerts to supervisors.
- The system integrates with cloud-based BreathLogix Connect platform for secure data logging and reporting across multiple locations.
Material Impact
- This news represents an execution update on the December 30, 2025 announcement regarding the first international distributor order with Breathalyser Sales & Service Pty Ltd.
- The specific sector expansion (Mining, Municipal, Aviation) confirms commercial traction but does not disclose contract values or revenue figures.
- Given the stock price decline from $0.75 on May 25 to $0.65 on May 28 prior to this release, the news serves as a stabilizing factor rather than a catalyst for significant upside without financial proof of scale.
- The Marijuana Breath Test (MBT) certification milestones achieved in May 2026 (UL/CSA) complement this alcohol screening expansion, diversifying revenue streams but maintaining reliance on partnership execution.
- No new capital raise or strategic investor entry is announced; dilution risk remains tied to previous financing structures.
BLO · Price
Company Overview
- Company: Cannabix Technologies Inc., a technology company focused on breath-based detection solutions for alcohol and cannabis impairment.
- Flagship Projects:
- BreathLogix: Alcohol screening system targeting safety-critical industries (Mining, Maritime, Aviation). Features unmanned access control integration.
- Marijuana Breath Test (MBT): Portable system detecting recent delta-9 THC use in breath within a 4-hour window using LC-MS analysis.
- Development Status:
- MBT has achieved UL/CSA certifications and FCC compliance. Peer-reviewed validation study published in Journal of Analytical Toxicology (March 2026).
- BreathLogix has secured NHTSA approval for the Workplace Series device and USPTO patent grant for contactless breath analysis (October 2025).
More from Cannabix Technologies Inc.
Jun 29, 2026 · 08:45